Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Br J Nutr ; 121(11): 1201-1214, 2019 06.
Artículo en Inglés | MEDLINE | ID: mdl-31130146

RESUMEN

We conducted a systematic review of randomised controlled trials (RCT) of increased intake of arachidonic acid (ARA) on fatty acid status and health outcomes in humans. We identified twenty-two articles from fourteen RCT. Most studies were conducted in adults. These used between 80 and 2000 mg ARA per d and were of 1-12 weeks duration. Supplementation with ARA doses as low as 80 mg/d increased the content of ARA in different blood fractions. Overall there seem to be few marked benefits for adults of increasing ARA intake from the typical usual intake of 100-200 mg/d to as much as 1000 mg/d; the few studies using higher doses (1500 or 2000 mg/d) also report little benefit. However, there may be an impact of ARA on cognitive and muscle function which could be particularly relevant in the ageing population. The studies reviewed here suggest no adverse effects in adults of increased ARA intake up to at least 1000-1500 mg/d on blood lipids, platelet aggregation and blood clotting, immune function, inflammation or urinary excretion of ARA metabolites. However, in many areas there are insufficient studies to make firm conclusions, and higher intakes of ARA are deserving of further study. Based on the RCT reviewed, there are not enough data to make any recommendations for specific health effects of ARA intake.


Asunto(s)
Ácido Araquidónico/administración & dosificación , Suplementos Dietéticos , Ácidos Grasos Insaturados/sangre , Adulto , Anciano , Ácido Araquidónico/sangre , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estado Nutricional , Ensayos Clínicos Controlados Aleatorios como Asunto
2.
Dis Aquat Organ ; 115(2): 129-37, 2015 Jul 23.
Artículo en Inglés | MEDLINE | ID: mdl-26203884

RESUMEN

The demand for ornamental fish has led to a steep rise in aquaculture for the hobbyist trade, promoting the emergence, persistence and spread of various infectious diseases. Complete control of disease outbreaks with antibiotics and chemical-based medicines is rare, but plant compounds may herald potential alternatives effective against a range of pathogens. Melafix® and Pimafix® are formulated with the essential oils cajuput (Melaleuca cajuputi) and West Indian bay (Pimenta racemosa) and are marketed against bacterial and fungal infections, respectively. Previous experiments showed high efficacy of emulsified cajuput oil against gyrodactylids; the current study tested Melafix® and Pimafix® and their individual compounds against Gyrodactylus turnbulli infecting the guppies Poecilia reticulata. In particular, a combination treatment of Melafix® and Pimafix® was highly effective at reducing in vitro survival of parasites from 15 to 2 h and eradicating 95% of gyrodactylids in vivo. The unexpected high efficacy of this combination treatment is likely explained by the high content of terpenes and phenol propanoids in the cajuput and West Indian bay oils, as well as the anti-helminthic properties of the emulsifier Crovol PK 70. Hence, Melafix® and Pimafix® effectively reduce gyrodactylid burdens on fish, increasing the chances of efficient disease control in ornamental fish.


Asunto(s)
Antiparasitarios/uso terapéutico , Enfermedades de los Peces/parasitología , Aceites de Plantas/uso terapéutico , Poecilia , Infecciones por Trematodos/veterinaria , Animales , Antinematodos/uso terapéutico , Infestaciones Ectoparasitarias/tratamiento farmacológico , Infestaciones Ectoparasitarias/veterinaria , Enfermedades de los Peces/tratamiento farmacológico , Laurus/química , Levamisol/uso terapéutico , Melaleuca/química , Aceites Volátiles/química , Aceites Volátiles/uso terapéutico , Aceites de Plantas/química , Trematodos/clasificación , Infecciones por Trematodos/tratamiento farmacológico
3.
Vet Parasitol ; 198(1-2): 96-101, 2013 Nov 15.
Artículo en Inglés | MEDLINE | ID: mdl-24074607

RESUMEN

Traditional compounds used to treat fish diseases in aquaculture and the ornamental fish industry (such as formalin and malachite green) can be more toxic to the hosts than their parasites. With the reviviscence in the use of herbal products, various botanicals have been heralded as cures for particular pathogens, but the efficacy of these compounds for parasitic worms is questionable. Here, we tested a range of garlic (Allium sativum) products against a major aquarium pathogen, Gyrodactylus turnbulli, infecting the guppy (Poecilia reticulata). All garlic products significantly reduced parasite mean survival time in vitro, from 13 h to <1 h. In fully randomised trials, the number of parasites was also significantly reduced on infected fish exposed to garlic from different sources. Two garlic treatments (minced and granule forms) reduced worm burdens by 66% and 75% after three doses, whereas Chinese freeze-dried garlic and allyl disulphide were 95% effective after a single application. In fact, Chinese freeze dried garlic was equally effective as Levamisole, a licensed livestock dewormer that is highly effective against G. turnbulli but not routinely prescribed for use in fish; hence, garlic may be a potential alternative treatment for gyrodactylosis.


Asunto(s)
Infestaciones Ectoparasitarias/veterinaria , Enfermedades de los Peces/tratamiento farmacológico , Ajo/química , Poecilia , Trematodos/clasificación , Infecciones por Trematodos/veterinaria , Compuestos Alílicos , Animales , Antiparasitarios/química , Antiparasitarios/uso terapéutico , Disulfuros/uso terapéutico , Infestaciones Ectoparasitarias/tratamiento farmacológico , Infecciones por Trematodos/tratamiento farmacológico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA